Sign in or Register
  |  

Creative Biolabs has successfully developed SARS, MERS and other anti-viral antibodies in the past to assist scientific research. Facing the difficult COVID-19, Creative Biolabs actively invests in antibody development to assist researchers to better understand the characteristics of 2019-nCoV and drug development. Currently, Creative Biolabs is proud to offer an extensive line of research antibodies to support the study of SARS-CoV-2/COVID-19, several of which were validated using virus-infected cell lysates.

Explore the collections of SARS-CoV-2/COVID-19 antibodies >

PLCL2

PLCL2 has ubiquitous expression in ovary (RPKM 4.0), lymph node (RPKM 3.4) and 23 other tissues.

Anti-PLCL2 antibodies

Loading...

Mouse Anti-PLCL2 Recombinant Antibody (2D10) (CBMAB-P2069-YC)

Target: PLCL2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 2D10
Application*: E, WB

Mouse Anti-PLCL2 Recombinant Antibody (1C7) (CBMAB-P2068-YC)

Target: PLCL2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: 1C7
Application*: E, IP, WB

Mouse Anti-PLCL2 Recombinant Antibody (CBYC-P430) (CBMAB-P2070-YC)

Target: PLCL2
Host: Mouse
Antibody Isotype: IgG2a, κ
Specificity: Human
Clone: CBYC-P430
Application*: WB, IP, E, WB

Mouse PLCL2 Peptide (AVVSFKEL) (PEP-191362CQ)

Target: PLCL2
Specificity: Mouse

Mouse PLCL2 Peptide (EFIEVFHEL) (PEP-191361CQ)

Target: PLCL2
Specificity: Mouse

Human PLCL2 Peptide (NEVLASKY) (PEP-161258CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (RPAIMREEV) (PEP-161257CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (EEISLEIIHKY) (PEP-161256CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (SVIDIINKY) (PEP-161255CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (RGGAAGGALP) (PEP-161254CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (LPTSPGPAL) (PEP-161253CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (SPRFLGPDNTPLVVL) (PEP-161252CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (FLLDADMQSL) (PEP-161251CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (FLGPDNTPLVVL) (PEP-161260CQ)

Target: PLCL2
Specificity: Human

Human PLCL2 Peptide (ALAPTPSAV) (PEP-161259CQ)

Target: PLCL2
Specificity: Human
(P): Predicted
* Abbreviations
IFImmunofluorescence
IHImmunohistochemistry
IPImmunoprecipitation
WBWestern Blot
EELISA
MMicroarray
CIChromatin Immunoprecipitation
FFlow Cytometry
FNFunction Assay
IDImmunodiffusion
RRadioimmunoassay
TCTissue Culture
GSGel Supershift
NNeutralization
BBlocking
AActivation
IInhibition
DDepletion
ESELISpot
DBDot Blot
MCMass Cytometry/CyTOF
CTCytotoxicity
SStimulation
AGAgonist
APApoptosis
IMImmunomicroscopy
BABioassay
CSCostimulation
EMElectron Microscopy
IEImmunoelectrophoresis
PAPeptide Array
ICImmunocytochemistry
PEPeptide ELISA
MDMeDIP
SHIn situ hybridization
IAEnzyme Immunoassay
SEsandwich ELISA
PLProximity Ligation Assay
ECELISA(Cap)
EDELISA(Det)
BIBioimaging
IOImmunoassay
LFLateral Flow Immunoassay
LALuminex Assay
CImmunohistochemistry-Frozen Sections
PImmunohistologyp-Paraffin Sections
ISIntracellular Staining for Flow Cytometry
MSElectrophoretic Mobility Shift Assay
RIRNA Binding Protein Immunoprecipitation (RIP)